Status:
COMPLETED
Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty
Lead Sponsor:
Temple University
Conditions:
Pain, Postoperative
Mammaplasty
Eligibility:
FEMALE
18-80 years
Phase:
PHASE2
Brief Summary
The addition of dexamethasone to non-liposomal bupivacaine in perineural blocks has been shown to enhance pain control and prolong the time until first request for postoperative narcotics in the field...
Detailed Description
The investigators conducted a double-blind randomized controlled trial to determine whether the addition of dexamethasone to bupivacaine in a preoperative Pecs II block resulted in improved pain contr...
Eligibility Criteria
Inclusion
- Female
- Age 18-80
- Bilateral reduction mammaplasty
- American Society of Anesthesiologists (ASA) physical status classification 1, 2, or 3
- Must choose to receive preoperative nerve block as part of pain management strategy
Exclusion
- Allergy to dexamethasone or bupivacaine
- History of postoperative nausea and vomiting following anesthesia
- History of chronic pain conditions
- History of narcotic abuse or dependency
- History of chronic renal disease
- History of chronic liver disease
Key Trial Info
Start Date :
September 29 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2020
Estimated Enrollment :
56 Patients enrolled
Trial Details
Trial ID
NCT04919317
Start Date
September 29 2017
End Date
November 25 2020
Last Update
October 11 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Temple University Hospital
Philadelphia, Pennsylvania, United States, 19140